TotalMarketCap

Roivant Sciences

ROIVNasdaq United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$25.664 B

$35.53 -0.70%

Close of 7 Oct 2026

As of 7 Oct 2026, Roivant Sciences (ROIV) has a market capitalization of $25.7B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$8.26M

#3189 by revenue

Earnings

-$299.8M

Loss-making

Shares outstanding

722,323,015

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #19Alnylam PharmaceuticalsALNY$30.0B
  2. #20ZoetisZTS$29.5B
  3. #21Roivant SciencesROIV$25.7B
  4. #22United TherapeuticsUTHR$23.2B
  5. #23InsmedINSM$23.0B

What if Roivant Sciences were worth as much as…

Open the what-if tool →

Gold $28.8T

$39,856.73

Per share 1,122× higher

Bitcoin $1.67T

$2,312.33

Per share 65.1× higher

Nvidia $5.77T

$7,982.14

Per share 225× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for Roivant Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.